Breathing disorders are common in the U.S. with conditions like COPD affecting some 7% of the population and asthma affecting another 10%. Digestive conditions like GERD, acid reflux, Celiac disease ...

A Regulation CF (Reg CF) offering is an investment security that startups and early-stage companies can issue as part of their push to raise capital. The “regulation” in Reg CF offerings references ...

A cystic fibrosis vest is a therapeutic tool. When worn, it provides compressions similar to manual chest percussions. Wearing the vest can help loosen sticky secretions so that a person can more ...

Cystic fibrosis is caused by genetic changes and is always present at birth. Although rare, cystic fibrosis isn’t diagnosed in some people who have mild symptoms until they’re adults. This is known as ...

Reports Q3 revenue $1.659B, consensus $1.65B. “The CF Industries (CF) team continues to deliver outstanding results, working safely and operating ...

They call it the Purge. You have experienced, in a modest way, something like it in the waning days of a bad cold, when your lungs finally expel their accumulated gunk. The rattle in your chest quiets ...

For the quarter ended September 2025, CF Industries (CF) reported revenue of $1.66 billion, up 21.1% over the same period last year. EPS came in at $2.19, compared to $1.55 in the year-ago quarter.

Non–cystic fibrosis bronchiectasis (NCFB) is a chronic inflammatory condition of the lungs associated with respiratory infections and daily cough and sputum. Non-cystic fibrosis bronchiectasis. Image ...

Vertex Pharmaceuticals Incorporated remains a buy despite recent share price weakness, supported by its dominant cystic fibrosis franchise and robust late-stage pipeline. Alyftrek's launch extends ...